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ABSTRACT 
Ghana is a known endemic area for hepatitis B virus (HBV) infections, yet the consequences of HBV 
infection on pregnancy outcomes are unknown. This prospective cohort study was thus conducted among 
512 pregnant women attending antenatal clinic in the Cape Coast Teaching Hospital, Ghana, between 
January, 2011 and December, 2013 to determine the effects of hepatitis B during pregnancy on birth 
outcomes in Ghana. The HBsAg status of all pregnant women was determined by the latex agglutination 
test while a researcher administered semi-structured checklist was used to collect 
demographic/obstetric/medical data of respondents. We obtained 262 HBsAg positive and 250 HBsAg 
negative women most of whom were aged 20-29 (40%), classified themselves as low income earners (50%), 
and had attained primary education (42%). Logistic regression analysis showed that pregnant women who 
had chronic hepatitis B were more likely to develop PROM (p=0.008) and foul smelling liquor (p=0.024) 
at delivery. Moreover, neonatal consequences for chronic hepatitis B were; preterm babies (p=0.002), 
underweight (p<0.001), Apgar score lower than 7 (p<0.001), asphyxia at birth (p=0.006) and still birth 
(p=0.04). We conclude that babies born to mothers with positive HBsAg status have a higher risk for 
vertical transmission as well as adverse neonatal consequences.  
Keywords; Hepatitis B, neonatal outcome, pregnancy outcome, Ghana 
INTRODUCTION 
Hepatitis B virus (HBV) infection in pregnancy 
is an important public health issue, particularly 
in developing countries. Hepatitis B virus is a 
DNA virus that could be transmitted 
percutaneously, sexually, or perinatally and over 
350 million individuals around the world are 
chronic carriers (Deinstag, 2008 and WHO, 
2000). Majority of the world’s chronic HBV 
infection carriers, especially children, acquire 
this infection via the perinatal route (Jonas, 2009 
and Lavancy, 2004). Compared to the adult, a 
child who develops HBV infection at an early 
age has about 80-90% greater chance of 
progressing into a chronic state and thus hepatic 
failure (Chang, 2000). Fifteen to 40% of HBV 
infected persons would develop cirrhosis of the 
liver, liver failure or hepatocellular carcinoma 
(Lok, 2002), and 500,000 – 1.2 million people 
die of HBV infection annually (Lee, 1997 and 
Mahoney, 1999). Sub Saharan Africa remains 
one of the highest endemic regions for HBV 
infection (WHO, 2000). An estimated 50 million 
cases of chronic HBV infection live in Africa 
(Blankson et al., 2005). In Ghana, sero-
prevalence rate of HBV infection ranges from 
6.7% to 10% in blood donors (Acquaye, 1991), 
15.6% in children (Martinson et al., 1996), and 
10.5% in pregnant women (Cho et al., 2012). 
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Acute hepatitis B may present as asymptomatic 
or with unspecific symptoms that make diagnosis 
challenging. Common signs associated with 
HBV infection include nausea, vomiting, 
anorexia, mild diarrhoea, malaise and pain over 
the abdomen. In the empty uterus these signs are 
similar to influenza but in the gravid uterus these 
signs could mimic signs of pregnancy and this 
may present a ‘unique challenge’ to diagnosis of 
HBV infection during pregnancy (Fraser et al., 
2003). Thus the presence of hepatitis B surface 
antigen (HBsAg) in the bloodstream remains the 
serological hallmark for diagnosis (Fraser et al., 
2003). In resource poor regions however, the 
facilities to conduct this test may not be readily 
available to the entire population so that the 
HBsAg status of the pregnant woman may not be 
known prior to labour. The practices of women 
in developing countries tend to increase their 
chance of contracting HBV infections. For 
instance, most women in developing countries, 
unfortunately, have insufficient knowledge 
regarding mode of transmission of hepatitis B 
(80%) and less than 10% of women of 
childbearing age are fully immunised against 
HBV infection (Sharma et al., 1996). 
The relationship between HBV infection and 
pregnancy is complex and incompletely 
understood. While most authors agree that 
pregnancy does not necessarily worsen liver 
function, other authors suggest there may be a 
change in liver size and blood flow in pregnancy 
(Fraser et al., 2003; Nguyen et al., 2009). In 
addition, the rare occurrence of intrahepatic 
cholestasis of pregnancy (ICP) have caused some 
authors to call careful interpretation of laboratory 
results in pregnancy and also for further studies 
into hepatic changes in pregnancy (Fraser et al., 
2003; Nguyen et al., 2009 and Potthoff et al., 
2009). Normal pregnancy is associated with high 
levels of adreno-corticosteroids, alanine 
aminotransferase (ALT) and oestrogen hormones 
resulting in increased HBV viremia (ter Borg et 
al., 2008). These hormonal and cytokine changes 
could also lead to fluctuations in liver function 
tests. 
Literature regarding the effects of Hepatitis B 
virus infection on pregnancy is sparse and results 
from these studies have found conflicting results. 
The few studies published on the subject have 
also been based predominantly in the Eastern and 
far Eastern countries. While some authors 
suggest that maternal HBV infection may be 
associated with adverse pregnancy outcomes like 
gestational diabetes, antepartum haemorrhage, 
birth defects, still births and preterm birth 
(Shepard, 1998; Ka, Lai and Terence, 2005; 
Gambarin-Gelwan, 2007; Safir et al., 2010; 
Elefsiniotis et al., 2010; Aghamohammadi and 
Nooritajer,  2011; and Borgia et al., 2012), other 
studies have suggested that acute HBV infection 
in pregnancy has no teratogenic effects (Jonas, 
2009; Wong et al., 1999; To et al., 2003; and 
Lobstein et al., 2011). Such conflicting results 
have been largely influenced by the research 
setting in which these studies were conducted. 
Studies conducted in high prevalence regions 
like Asia were more likely to report significant 
associations, compared to studies in low endemic 
areas like the United Kingdom (Ma and Bauman, 
1996; Chen et al., 2000; and Kawsar and Goh, 
2002). On the contrary, other studies conducted 
in low endemic regions that have reported high 
incidence of adverse pregnancy outcomes among 
pregnant women born in high endemic regions 
(Von Katterfield et al., 2011). The authors, 
unfortunately, did not measure the HBV status of 
pregnant women (Von Katterfield et al., 2011). 
A suggestion that these excess deaths in women 
of high endemic regions may be related to their 
HBV statuses, however, may not be misplaced. 
Birth weight is perhaps the only pregnancy 
outcome that has been studied extensively with 
regards to its relationship with maternal HBsAg 
status. Yet the results of several studies have not 
been consistent. Many studies have found a 
significant positive relationship between a 
positive maternal HBsAg status and infant birth 
weight, despite no differences in obstetric 
complications (Lao et al., 2012) and others have 
found negative associations (Shepard, 1998). In a 
large retrospective cohort study in China, Lao et 
al. found that HBsAg status was significantly 
associated with marcrosomic infants after 
adjusting for sex, BMI, age and gestational 
diabetes mellitus (OR; 1.11), but significant 
associations were observed for the male gender. 
Although in some medical literature, a positive 
association between infant macrosomia (birth 
weight >4kg) and gestational diabetes mellitus 
has been recorded (Lao et al., 2012 and 
Gambarin-Gelwan, 2007), other studies have 
reported the opposite (Tse et al., 2005; and Lao 
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et al., 2007). This contrary observation has made 
interpretation of the effects of infant macrosomia 
associated with positive maternal HBsAg status 
challenging. On one hand, if maternal HBV 
infection increases foetal growth and size, then 
this could be beneficial as low birth weight is 
associated with future cardiovascular 
complications (Saleh-Gargari et al., 2009; Mi et 
al., 2000; Hardy et al., 2005; and Whincup et al., 
2008). On the other hand, however, infant 
macrosomia could be a risk factor for adolescent 
obesity, diabetes mellitus and cancer (Okasha et 
al., 2002; Hjalgrim et al., 2004; and Fomulu et 
al., 2013). Clarification of the effects of maternal 
HBV infection on pregnancy outcomes is thus 
very important especially in endemic regions.  
MATERIALS AND METHODS 
Research design 
This was a prospective cohort study conducted 
among pregnant women attending antenatal 
clinic in the Cape Coast Teaching Hospital, 
Ghana between January 2011 and December 
2013. These pregnant women were followed 
over the study period, from the time of 
recruitment at antenatal clinic until they were 
delivered. Demographic, medical and obstetric 
data of the pregnant women were taken at 
recruitment and data on the characteristics of 
their babies, birth outcomes and mode of 
deliveries were collected at the end of the study. 
Informed consent was obtained from the 
pregnant women prior to data collection. The 
authors also obtained ethical clearance from the 
Institutional Review Boards of the University of 
Cape Coast and the Cape Coast Teaching 
Hospital, Ghana. 
Demographic, obstetric and medical data 
collected from pregnant women were; age, 
education, employment status, parity, premature 
rupture of membranes (PROM), antenatal 
attendance, mode of delivery, maternal urinary 
tract infection/sexually transmitted infections 
(UTI/STI), bleeding during pregnancy/APH, 
history of previous abortion, pregnancy-induced 
hypertension (PIH), foul smelling liquor, and 
prolonged labour. Characteristics of babies born 
to the pregnant women included in this study 
were; sex, gestational age, birth weight, Apgar 
score at minute one and five, birth outcome and 
level of oxygenation at birth. 
At recruitment, the pregnant women were 
categorized into exposed and not-exposed groups 
based on their HBsAg status. In Ghana, all 
pregnant women undergo medical screening 
during the antenatal period and this includes a 
test for the hepatitis B status. The HBsAg status 
of all pregnant women included in the study was 
thus checked from patient’s folder and confirmed 
by the latex agglutination test, a serological test 
for HBsAg done by a registered biomedical 
scientist according to the standard protocols of 
the Ghana Health Service. An exposed group 
was determined as a pregnant woman who had 
seroconverted for HBsAg for six months or 
more. An internal comparison group of pregnant 
women who had not seroconverted for HBsAg 
was selected as a not-exposed group. A cohort 
study, using an internal comparison group, was 
preferred because the incidence of hepatitis B 
among pregnant women in Ghana, though not 
known by certainty, is perceived to be small as in 
neighbouring African countries of similar 
demographics (Fomulu et al., 2013). For the 
purpose of this study, a pregnant woman in the 
exposed group, i.e. with Hepatitis B, would be 
referred to as case and a pregnant woman 
without hepatitis B would be referred to as 
control. 
A researcher developed semi-structured checklist 
was developed as the main instrument for data 
collection. The contents of the checklist were 
based on hypothesised demographic, medical, 
obstetric and neonatal characteristics likely to be 
influenced by chronic Hepatitis B infection. The 
checklist was pretested in a pilot study before its 
use in the present study. Research assistants, 
mostly midwives, were specially trained on the 
use of the instrument so they could administer 
the checklist.  
Conceptual definitions 
Premature infant:  a live born infant delivered 
before 37 weeks of pregnancy (based on the 
Ballard score or from first day of last menstrual 
period). 
Low birth weight: A neonate whose birth weight 
is <2.5 kilograms. Birth weight was determined 
Sept. 2014. Vol. 4, No.5                                                                                                ISSN 2307-2083            
                           International Journal of Research In Medical and Health Sciences    
                                                    © 2013-2014 IJRMHS & K.A.J. All rights reserved                
                        http://www.ijsk.org/ijrmhs.html                                                                                                                                 
 
 
4 
 
at birth for each neonate using a standardised and 
calibrated infant weighing scale. The neonate 
was undressed and put on the scale in a ventral 
position. 
Premature rupture of membranes (PROM): the 
time from membranes’ rupture to onset of 
delivery more than 18 hours. 
Meconium stained amniotic fluid (MSAF): was 
considered if the amniotic fluid was green in 
colour or mixed with meconium, or appears 
meconium stained in the baby. 
Asphyxia: Apgar score less than 3 in the first 5 
minutes from delivery. 
Statistical analysis 
Data from the checklist were processed and 
analysed using computer assisted Statistical 
Package for Social Sciences Version 20.32 
(SPSS ver. 20.32). Pearson’s chi-squared was 
used to determine significant differences, if any, 
between cases and controls with respect to the 
several outcome or dependent variables included 
in this study. Thus significant associations 
between dependent maternal and neonatal 
characteristics and the independent variable, 
HBsAg status, of the mothers were determined. 
Logistic regression analyses were used to 
determine the risk of maternal hepatitis B 
infection for maternal and neonatal outcomes, 
compared to a reference parameter of a variable. 
Mean differences were considered statistical 
significant a p-value <0.05. 
RESULTS 
The study comprised 512 mothers and their 
respective babies. The average age of mothers in 
this study was 20-29 years, considered herself of 
low income earning status, had attained a 
primary education, and lived in a rural setting. 
Table 1 shows the distribution of the 
demographic characteristics of cases and 
controls. It is clear there was no statistically 
significant difference between the case and 
control groups in terms of age (p=0.683), income 
(p=0.329), educational level (p=0.339), and 
residence (p=0.326). The groups were thus 
comparable.
Table 1: Socio-demographic Characteristics of Respondents 
Parameters Variables Case (n=262) Control (n=250) X
2
 p-value 
Age <20 
20 – 29  
30 – 39  
≥ 40 
54 
104 
72 
32 
50 
102 
60 
38 
 
 
1.498 
 
 
0.683 
Income Low 
Medium 
High 
124 
90 
48 
132 
71 
47 
 
2.223 
 
0.329 
Educational 
Level 
Illiterate  
Primary 
Secondary 
Tertiary 
91 
101 
42 
18 
92 
112 
28 
18 
 
 
3.366 
 
 
0.339 
Residence Rural 
Urban 
160 
102 
142 
108 
 
0.964 
 
0.326 
 
Table 2 presents the maternal obstetric 
characteristics of the mothers who participated in 
this study. Majority of the mothers had one child 
(77%), did not have history of premature rupture 
of membranes, PROM (73%), did not have PIH 
(75%), and did not have history of foul smelling 
liquor (85%), no history of previous abortion or 
history of UTI/STI (79%). Results of chi squared 
analysis showed significant differences between 
cases and controls in terms of parity (p=0.001), 
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PROM (p=0.008), foul smelling liquor 
(p=0.024), and maternal history of UTI/STI 
(p=0.005). Compared to mothers who had one 
child, mothers with hepatitis B were less likely 
to two children (OR= 0.315; 95% CI: 0.13-0.68) 
but more likely to have three or more children 
(OR= 1.54; 95% CI: 0.95-2.5). The study also 
observed that mothers with positive HBsAg 
status were more likely to have PROM 
(OR=1.71 95% CI: 1.151 – 2.556), foul smelling 
liquor (OR= 2.023 95% CI: 1.093 – 3.889), and 
HO/UTI/STI (OR= 1.854 95% CI: 1.198 –
2.902).  There were no significant differences 
between the case and control groups in terms of 
PIH and previous abortions and the confidence 
interval for the association between Hepatitis B 
in the mother and parity overlapped 1. Therefore 
it is likely the result happened by chance.
Table 2: Maternal Obstetric Characteristics of Respondents  
Parameters Variables Case 
(n=262) 
Control 
(n=250) 
X
2
 P-
Values 
Odd 
Ratio 
CI 
Lower Upper 
Parity 1 201 192 13.294 0.001    
2 27 8   0.315 0.130 0.684 
≥ 3 34 50   1.536 0.954 2.499 
PROM Present 84 54 7.111 0.008 1.710 1.151 2.556 
Absent 178 196      
PIH Present 71 55 1.793 0.181 1.317 0.879 1.980 
Absent 191 195      
Foul Smelling 
Liquor 
Present 32 16 5.089 0.024 2.023 1.093 3.889 
 Absent 230 234      
Previous 
Abortion 
Present 43 36 0.397 0.529 1.166 0.720 1.897 
Absent 219 214      
HO/UTI/STI Present 67 39 7.750 0.005 1.854 1.198 2.902 
Absent 195 211   1.143   
 
Table 3 shows foetal birth outcomes of mothers 
with and without Hepatitis B. The differences in 
the distributions of gestational age, birth weight, 
Apgar score at first minute, Apgar score at fifth 
minute, birth outcome, and asphyxia is shown by 
chi squared analysis and the risk of outcome in 
the case and control groups is shown by odds 
ratios of the logistic regression analysis. Results 
of chi-squared analyses reveal significant 
differences in gestational age (0.002), birth 
weight (<0.001), Apgar scores at first (<0.001) 
and fifth minute (<0.001), birth outcome (0.04), 
and asphyxia status at birth (0.006). Cases were 
significantly more likely to have preterm babies 
than controls (27% vs 16%), more likely to have 
children of low birth weight than controls (29% 
vs 16%), more likely to have children of Apgar 
scores less than 7 than controls (26% vs 9%), 
more likely to have children still birth than 
controls (4% vs 1%) and more likely to have 
asphyxiated babies than controls (11% vs 9%).  
Results of logistic regression analysis showed 
that mothers with hepatitis B were about twice 
more likely to have preterm babies [1.98 (1.29-
3.08)], deliver babies with low birth weight [2.2 
(1.44-3.43)] and babies with Apgar score less 
than 7 in the first minute [2.03 (1.38-3.01)]. 
Mothers with hepatitis B were 70% less likely 
than mothers without hepatitis B to have babies 
born alive [0.29 (0.062-0.95)]. Mothers with 
hepatitis B were again more likely to have babies 
born asphyxiated, however the confidence 
interval overlapped 1[1.23 (0.69-2.21)], thus the 
possibility that this result occurred by chance 
cannot be ruled out. 
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Table: 3 Neonatal Characteristics of Infant Born to Respondent 
Parameters Variables Case 
(n=262) 
Control 
(n=250) 
Chi-
Square 
P-
Values 
Odd 
Ratio 
CI 
Lower Upper 
Gestational 
Age 
Preterm 
Term  
72 
190 
40 
210 
 
9.867 
 
0.002 
 
1.984 
 
1.291 
 
3.084 
Birth Weight <2500g 
≥2500g 
76 
186 
39 
211 
 
13.205 
 
<0.001 
 
2.204 
 
1.435 
 
3.428 
Apgar Score 
at 1 min 
< 7 
≥ 7 
97 
165 
56 
194 
 
13.055 
 
<0.001 
 
2.032 
 
1.380 
 
3.012 
 Apgar Score at 
5 min 
< 7 
≥ 7 
68 
194 
22 
228 
 
25.983 
 
<0.001 
 
3.608 
 
2.180 
 
6.186 
Birth 
Outcome 
Live 
Still Birth 
251 
11 
247 
3 
 
4.325 
 
0.038 
 
0.288 
 
0.062 
 
0.951 
Asphyxia Present 
Absent 
29 
233 
23 
227 
 
7.461 
 
0.006 
 
1.226 
 
0.688 
 
2.208 
 
DISCUSSION 
This study is first to investigate the 
consequences of chronic hepatitis B virus 
infection among pregnant women on the 
outcome of pregnancy in Ghana. The study 
included a total of 512 pregnant women; 262 
classified as HBsAg positive and 250 as HBsAg 
negative. Although the study methodology 
employed in this study does not allow us to 
determine the prevalence of hepatitis B among 
pregnant women in Ghana, it could be said that 
pregnant women aged between 20-29 years, of 
low income status, had attained a maximum of 
primary education and lived in a rural setting 
were overrepresented in the sample of pregnant 
women with hepatitis B. Many studies published 
on the prevalence of hepatitis B among pregnant 
women or women for that matter concur that 
women aged less than 30 and of less 
socioeconomic status are at higher risk for 
contracting Hepatitis B (El-Shabrawi et al., 2013 
and Esan et al., 2014). Medical literature on the 
lifestyle practices which influence HBV 
infection is not lacking (Lewis et al., 2014; 
Wong et al., 2006). All these studies agree that 
factors that predispose women to sexually 
transmitted infections in general-multiple sex 
partners, multiple STIs, sharing of sharps- also 
predispose women to contracting hepatitis B. 
Women who live in rural settings and are of 
lower income status are likely to engage in these 
‘risky’ behaviours. Other studies have also 
identified that women in rural settings and of 
lesser education had insufficient knowledge 
regarding HBV infection and its mode of 
transmission (Sharma et al., 1996 and Chandan 
et al., 2012).
 
Neonatal Consequences 
Many authors agree that the presence of hepatitis 
B infection during pregnancy has more 
detrimental effects for the foetus and neonate 
than the mother (Fraser et al., 2003 and Wong et 
al., 2006). It is established that neonates born to 
mothers with hepatitis B stand a greater chance, 
about 90%, of acquiring HBV infection at birth 
(Chang, 2000). Without immunisation, or if 
immunisation is unable to clear the infection, 
neonates who acquire infections at an early age 
are at an increased risk of progressing to 
chronicity or hepatocellular carcinoma in the 
worst situation (Chang, 2000). This study 
observed that babies born to mothers with 
chronic hepatitis B infection have higher risk for 
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preterm birth, low birth weight, lower APGAR 
score at birth (<7) and neonatal asphyxia at birth. 
Studies on the effects of hepatitis B infection in 
mothers on neonatal outcomes is insufficient, 
however literature on the effects of neonatal 
sepsis on neonatal outcomes is not lacking 
(Chandan et al., 2012 and West and Tabansi, 
2012). Most of these studies on the effects of 
neonatal sepsis on neonatal outcomes have 
maintained the classical definition for defining 
neonatal sepsis as an infection occurring within 
28 days of birth. Thus by this definition, a 
neonate who acquires hepatitis B infection at 
birth may be classified as having neonatal sepsis. 
Yet it is known that almost all (9 out of 10) 
babies born to mothers with hepatitis B would 
acquire the infection (Chang, 2000). 
Unfortunately, previous studies on the effects of 
neonatal sepsis on neonatal outcome did not 
adjust for maternal hepatitis B, thus it is not out 
of place to suggest that studies that found 
positive relationships between neonatal sepsis on 
neonatal outcomes could apply to neonatal 
hepatitis B infection. When findings of the 
current study are viewed in the lens that neonates 
born to mothers with HBV infections had the 
infection, it would then follow the biological 
mechanism that neonates with sepsis, in   
this case HBV infection, would have weak 
defences for extra uterine life, thus the adverse 
consequences observed (Shah et al., 2006 and 
Al-Dasoky et al., 2005). We however, explain 
these findings with caution, as we were unable to 
determine the hepatitis B status of neonates born 
to HBsAg positive mothers in the present study. 
Neither could we adjust for some characteristics, 
maternal demographics for example, thus an 
alternative explanation of confounding may not 
be easily dispelled (Webb and Bain, 2011).
 
The few studies published on the neonatal 
consequences of maternal hepatitis B infection in 
pregnancy have concentrated on infant birth 
weight, but results from these studies is not 
consistent (Shepard, 1998; Wong et al., 2003; 
Lao et al., 2012). In a recent Chinese study on 
the effect of maternal hepatitis B infection on 
infant size, Lao et al. found a positive maternal 
HBsAg status to be associated with high birth 
weight. Other studies however, have found no 
association between maternal HBsAg status and 
infant size (Wong et al., 2003). Lao et al., 
suggests that since maternal hepatitis B status is 
associated with gestational diabetes (Tse et al., 
2005), and gestational diabetes is associated with 
infant marcosomia, therefore, it is not surprising 
that maternal hepatitis B may be associated with 
high birth weight. It is however, not known 
whether an increased birth weight for babies 
born of mothers with Hepatitis B may be 
beneficial or would have long term detrimental 
consequences, especially in developing 
countries. This study supports previous findings 
which found a negative association between a 
mother with chronic hepatitis B and infant size 
(Wong et al., 2003). In the current study, babies 
who weighed less than 2.5kg at birth were about 
2 times more likely to have mothers who had 
positive HBsAg status during pregnancy. This 
association could be due to the observation that 
mothers with hepatitis B in this study were more 
likely to be of low socio economic status, gained 
less education and lived in rural settings. These 
factors, unfortunately, are also associated with 
low birth weight. Given contrasting evidence 
from this study and previous ones regarding the 
effect of maternal hepatitis B infection on birth 
weight, it would have been ideal to determine 
which of the two, an increase birth weight or low 
birth weight would have detrimental effects on 
the health of the neonate. This is however, 
beyond the scope of the current study, thus 
further studies are recommended. 
This study agrees with former studies that found 
that maternal HBsAg status was associated with 
preterm birth. The possible theory underlying 
this relationship could be the general effects of 
neonatal infections on birth outcome (Nithin et 
al., 2009). The significant increase in pro 
inflammatory cytokines among pregnant women 
with chronic hepatitis B (Sheron et al., 1991; 
Bozkaya et al., 2000 and Luppi et al., 2002) 
could be an alternative explanation to the 
significant number of preterm births among 
mothers with chronic hepatitis B infection in this 
study. Mothers with a positive HBsAg status 
were found to be more likely to have neonates 
with low APGAR scores at birth and neonatal 
asphyxia compared to women with a negative 
HBsAg status. Previous studies on these 
variables are rare. 
Maternal Consequences 
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To date only a few of studies have sought to 
determine the effects of chronic HBV infection 
on pregnancy outcomes. A few of these studies 
focusing on maternal HBsAg carrier status and 
pregnancy outcome have reported that, HBsAg 
positive mothers  have an increased risk for 
adverse pregnancy outcomes including maternal 
complications (Ka et al., 2005; Gambarin-
Gelwan, 2007; and Aghamohammadi and 
Nooritajer, 2011). Results of this study showed 
significant positive relationship between a 
positive HBsAg status of mother in pregnancy 
and PROM and foul smelling liquor. There was 
however no association between pregnancy-
induced hypertension (PIH) and previous 
abortions and HBsAg carrier status.  
It remains true that scientific evidence regarding 
the effects of chronic hepatitis B infection of 
mother in pregnancy on maternal outcomes in 
pregnancy is inadequate. It is not clear whether 
indeed studies regarding this area are yet to be 
published or it is due to the possibility of 
publication bias, where studies that found 
insignificant relationships were not published. 
Another alternative explanation could be that 
scientists are yet to develop interest for this area 
of research. But this is unlikely, as earlier studies 
regarding hepatitis B have been published over 
two decades. The inherent methodological 
challenge associated with investigating the 
effects of a disease on pregnancy outcomes could 
be another challenge. This is because a cohort 
study, at best, may be the highest form of 
evidence or most rigorous study that may answer 
such research questions as it would be unethical 
to use an experimental design, a randomised 
controlled trial for example (Carneiro and 
Howard, 2011). Observational studies, including 
cohort studies, have serious limitations- residual 
confounding for example which limits an 
inference for a causal relationship.  
Biological explanations to the possible 
mechanism underlying the relationship between 
hepatitis B and pregnancy outcomes are not 
convincing. However, Luppi et al. believes that 
the increase in pro inflammatory cytokines 
associated with chronic hepatitis B infection in 
pregnancy may be responsible for the heightened 
adverse outcomes observed in positive HBsAg 
mothers. This belief may be supported by the 
clear evidence of the effects of liver cirrhosis, a 
possible end stage of chronic hepatitis B, on 
pregnancy outcomes. Many studies agree that 
liver cirrhosis during pregnancy has detrimental 
consequences for the mother (Tan et al., 2008; 
Shaheen and Nyers, 2010; and DegliEsposti and 
Shah, 2011). 
Significant positive relationship observed 
between a positive HBsAg status of mother in 
pregnancy and PROM and foul smelling liquor 
in this study is not surprising. Earlier  studies 
have identified PROM (Vinodkumar et al., 2009; 
Giogiana et al., 2010; and West and Tabansi, 
2012), maternal UTI/STI (Webb and Bain, 2011) 
and foul smelling liquor (Shah et al., 2006 and 
West and Tabansi, 2012)
 
as significant risk 
factors for neonatal sepsis. The risk for vertical 
transmission of HBV infection to neonates born 
to HBsAg positive mothers has been discussed 
earlier. It therefore makes sense that PROM and 
foul smelling liquor were identified as 
consequences of chronic HBV infection in 
pregnancy. This argument may validated by the 
fact that this study did not observe PIH or history 
of previous abortions as consequences of chronic 
HBV infection in pregnancy as none of these are 
risk factors for HBV infections. The authors 
suggest further studies to investigate this.  
CONCLUSION 
Babies born to mothers with positive HBsAg 
status have higher risk for vertical transmission 
as well as adverse neonatal consequences. 
Mothers with positive HBsAg during pregnancy 
are also likely to suffer some adverse outcomes. 
It is recommend that mothers with positive 
HBsAg status receive immunoprophylaxis and 
immunisations for HBV infection for babies be 
completed for all children. Further studies 
regarding long term consequences of HBV 
infection in pregnancy is recommended. 
STRENGHTS AND LIMITATIONS 
The main strength of this study is that it is the 
first study in Ghana, as far as the authors are 
concerned, to have investigated the 
consequences for Hepatitis B in pregnancy. 
Previous attempts to document on this subject 
focused on Hepatitis E rather than Hepatitis B 
(Bonney et al., 2012). Another, strength of this 
study which distinguishes it from previous 
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studies is the rigorous methodology employed. 
Unlike a previous study which was a case report 
on 3 people (Bonney et al., 2012), this study had 
a large sample size which increased the power of 
the study, a longitudinal study design and a 
population wide study. Classification of 
exposure status, hepatitis B status of pregnant 
women, was also based on biochemical tests 
rather than self-reportage which although would 
have made study cheaper yet would not be 
devoid of information bias.  
The main outcome measure in this study was the 
odds ratio of outcome (dependent variables), 
which was estimated as the odds of outcome in 
cases divided by the odds of outcome in the 
controls (Carneiro and Howard, 2011). 
Unfortunately, pregnant women selected for this 
study was based on their HBsAg status, rather 
than a random sample from a population of 
pregnant women. Thus while we acknowledge 
that this study could not determine, directly, the 
prevalence or incidence of hepatitis B among 
pregnant women in the general population, the 
odds ratio of outcome as determined in this study 
provided good information on the possible 
effects of perinatal hepatitis B on pregnancy 
outcomes. 
The last methodological challenge facing this 
study is that the authors reported unadjusted 
odds ratios as measure of association. While the 
use of odds ratios to measure associations is 
justified, the inability to adjust for possible 
confounding factors make an alternative 
explanation in favour of confounding factors 
plausible. Again, the use of an observational 
design means the authors cannot infer a causal 
relationship for results observed. An 
observational study, however, seem the best 
approach to investigate the consequence of 
chronic hepatitis B virus infection on pregnancy, 
as an experimental approach would not pass 
ethical approval! 
REFERENCES 
1. Acquaye JK (1991). Hepatitis Bs 
Antigen Carrier status among Ghanaian 
blood donors. Ghana Med. J. 25: 366 - 
368. 
2. Al- Dasoky AH, Faten Al- Awasheh 
NF, Kaplan MN, Hanadi A, Al- Rimawi 
AH, Aga MR, Abu-Setteh HM (2005). 
Risk Factors for Neonatal Sepsis in 
Tertiary Hospital in Jordan. J. Royal 
Med. Serv. 16.   
3. Aghamohammadi A, Nooritajer M: 
Maternal HbsAg carrier and pregnancy 
outcome. Australian Journal of Basic 
and Applied Sciences 2011, 5(31): 607 -
610.  
4. Blankson A, Wiredu EK, Gyasi RK, 
Adjei A, Tettey Y (2005). 
Seropevalence of hepatitis B and C 
virus in cirrhosis of the liver in Accra, 
Ghana. Ghana Med. J. 39(4): 134 – 137.  
5. Bonney JHK, Kwame-Aryee RA, Obed 
S, Tamatey AA, Barnor JS, Armah NB, 
Oppong SA, Osei-Kwesi M (2012). 
Fatal hepatitis E viral infection in 
pregnant women in Ghana: a case 
series. BMC Research Notes. 5: 478. 
6. Borgia G, Carleo MA, Gaeta GB, 
Gentile I (2012). Hepatitis B in 
pregnancy. World J. Gastroenterol. 
18(34): 4677 - 4683.  
7. Bozkaya H, Bozdayi M, Turkyilmaz R, 
Sarioglu M, Cetinkaya H, Cinar K 
(2000). Circulating IL – 2, IL – 10 and 
TNF- alpha in chronic hepatitis B: their 
relations to HBeAg status and the 
activity of liver disease. 
Hepatogastroenterology. 47: 1675- 
1679. 
8. Cameroon: is perinatal transmission of 
HBV neglected in Cameroon? BMC 
Pregnancy and Childbirth. 13:158. 
9. Carneiro I, Howard N (2011). 
Introduction to Epidemiology. 2nd 
edition. Open University Press. UK. 
10. Chandan KS, Sanjoy KD, Kamrul HS, 
Jubair C, Mannan AM, Jashimuddin 
MD, Tariqul IMD, Mohammod S 
(2012). Neonatal Sepsis: A Review. 
Bangladesh J. Child Health. 36(2): 82 - 
89. 
11. Chang MH (2000). Natural history of 
hepatitis B virus infection in children. J. 
Gastroenterol. Hepatol. 15 suppl E: 16–
19. 
12. Chen CJ, Wang LY, Yu MW (2000). 
Epidemiology of hepatitis B virus 
infection in the Asia-Pacific region. J. 
Gastroenterol. Hepatol. suppl:E3-6. 
Sept. 2014. Vol. 4, No.5                                                                                                ISSN 2307-2083            
                           International Journal of Research In Medical and Health Sciences    
                                                    © 2013-2014 IJRMHS & K.A.J. All rights reserved                
                        http://www.ijsk.org/ijrmhs.html                                                                                                                                 
 
 
10 
 
13. Cho Y, Bonsu G, Akoto Ampaw A, 
Nkrumah- Mills G, Nimo JJA, Park JK, 
Ki M (2012). The prevalence and risk 
factors for hepatitis B surface Ag 
positivity in pregnant women in Eastern 
Region of Ghana. Gut Liver. 6(2):235 - 
240. 
14. DegliEsposti S, Shah D (2011). 
Hepatitis B in pregnancy: challenges 
and treatment. Gastroenterol. Clin. 
North Am. 2011. 40: 355–372.  
15. Deinstag DL (2008). Hepatitis B virus 
infection. N. Engl. J. Med. 359: 1486-
1500. 
16. El-Shabrawi M, Mohamed FM et al. 
(2013). Prevalence of hepatitis B virus 
infection among Egyptian pregnant 
women - A single center study. Int. J. of 
Trop. Dis. and Health. 3(2): 157 – 168. 
17. Esan AJ, Omisakin CT, Ojo-Bola T, 
Owoseni MF, Fasakin KA, Ogunleye 
AA (2014). Sero-prevalence of hepatitis 
B and hepatitis C virus co-infection 
among pregnant women in Nigeria. Am. 
J. Biomed. Res. 2(1): 11 - 15. 
18. Fomulu NJ, Morfaw FL, Torimiro JN, 
Nana, P, Koh MV, William T (2013). 
Prevalence, correlates and pattern of 
Hepatitis B among antenatal clinic 
attenders in Yaounde-Cameroon: is 
perinatal transmission of HBV 
neglected in Cameroon? BMC Preg. 
And Childbirth.  13: 158. 
19. Fraser DM, Cooper AM, Nolte AGW 
(2003). Myles Textbook for Midwives. 
African Edition. Elsevier Publishers. 
UK. 
20. Giogiana FB, Ioan S, Ioan M, Marioara 
B, Elena P, Calin P, Nilima K (2010). 
Sepsis in newborns. TMI. 60 (4).  
21. Hardy R, Sovio U, King VJ, et al. 
(2005). Birth weight and blood pressure 
in five European birth cohort studies; an 
investigation of confounding factors. 
Eur. J. Pub. Health. 16: 21 - 30. 
22. Hjalgrim LI, Rostgaard K, Hjalgrim H, 
et al. (2004). Birth weight and risk for 
childhood leukemia in Denmark, 
Sweden, Norway, and Iceland. J. Nati. 
Cancer Inst. 96: 1549 - 1556. 
23. Jonas MM  (2009). Hepatitis B and 
Pregnancy: an underestimated issue. 
Liver Int. 29 suppl 1:133-139. 
24. Ka YT, Lai FH, Terence L (2005). The 
impact of maternal HBsAg carrier status 
on pregnancy outcomes. A case- control 
study. J. Hepatology. 43:771 - 775.  
25. Kawsar M, Goh BT (2002). Hepatitis B 
virus infection among Chinese residents 
in the United Kingdom. Sex. Transm. 
Infect. 78:166 - 168. 
26. Lao TT, Sahota DS, Suen SSH, Law 
LW, Leung TY (2012). Maternal 
HBsAg status and infant size – a 
Faustian bargain? J. Viral Hep. 19:519-
524. 
27. Lavanchy D (2004). Hepatitis B virus 
epidemiology, disease, burden, 
treatment, and current emerging 
prevention and control measures. J 
Viral. Hepat. 11:97-107. 
28. Lee WM (1997). Chronic hepatitis B. 
N. Engl. J. Med. 337:1733-1745 
29. Lewis S, Dirksen SR, Heitkemper MM, 
Bucher L. (2014). Medical Surgical 
Nursing. Eighth edition. Elseivier. 
USA. 
30. Lok AS (2002). Chronic hepatitis B. N. 
Engl. J. Med. 346:1683-1683 
31. Luppi P, Haluszczak C, Trucco M, 
Deloia JA (2002). Normal pregnancy is 
associated with peripheral leukocyte 
activation. Am. J. Reprod. Immunol. 
47: 72 - 81. 
32. Mahoney FJ (1999). Update on 
diagnosis, management, and prevention 
of hepatitis B virus infection. Clin. 
Microbiol. 12:351-366.  
33. Martinson FE, Weigle KA, Mushawar 
IK, Weber DJ, Royce R, Lemon SM 
(1996). Seroepidemiology survey of 
hepatitis B and C virus infections in 
Ghanaian children. J. Med. Virol. 
48:278 - 283. 
34. Nguyen G, Garcia RT, Nguyen N, Trinh 
H, Keeffe EB, Nguyen MH (2009). 
Clinical course of hepatitis B virus 
infection during pregnancy. Aliment. 
Pharmacol. Ther. 29: 755 - 764. 
35. Potthoff A, Rifai K, Wedemeyer H et 
al. (2009). Successful treatment of 
fulminant hepatitis B during pregnancy. 
Z. Gastroenterol.  47:667 - 670. 
36. ter Borg MJ, Leemans WF, de Man RA, 
Janssen HL (2008). Exacerbation of 
Sept. 2014. Vol. 4, No.5                                                                                                ISSN 2307-2083            
                           International Journal of Research In Medical and Health Sciences    
                                                    © 2013-2014 IJRMHS & K.A.J. All rights reserved                
                        http://www.ijsk.org/ijrmhs.html                                                                                                                                 
 
 
11 
 
chronic hepatitis B infection after 
delivery. J. Viral Hepat. 15:37 - 41. 
37. Shepard TH (1998). Catalog of 
Teratogenic Agents. Baltimore John 
Hopkins University Press. 
38. Gambarin-Gelwan MB (2007). 
Hepatitis B in pregnancy. Clin. Liver 
Dis. 11(4):945 -963. 
39. Safir A, Levy A, Sikuler E, Sheiner E 
(2010). Maternal Hepatitis B virus or 
Hepatitis C virus carrier status as an 
independent Risk Factor for adverse 
perinatal outcome. Liver Int. 30:765 - 
770. 
40. Elefsiniotis T, Tsoumakas K, Vezali E, 
Glynou I, Drakoulis N, Saroglou G 
(2010). Spontaneous Preterm Birth in 
Women with Chronic Hepatitis B Virus 
Infection. Int. J. Gynecol. Obstet. 
110:240 – 244. 
41. Lobstein S, Faber R, Tillmann HL 
(2011). Prevalence of hepatitis B and its 
impact on pregnancy and newborn 
complications at a tertiary hospital in 
the Eastern part of Germany. Digestion. 
83: 76 - 82. 
42. Ma J, Bauman A (1996). Obstetric 
profiles and pregnancy outcomes of 
Immigrant women in New South Wales. 
Aust. N. Z. J. Obstet. Gynaecol. 36:119 
– 125. 
43. Von Katterfield B, Li J, McNamara B, 
Langridge AT (2011). Obstetric profiles 
of foreign- born women in Western 
Australia using data linkages 1998-
2006. Aust. N. Z. J. Obstet. Gynaecol. 
51: 225 - 232. 
44. Sharma R, Malik A, Rattan A, Iraqi A, 
Maheshwari V, Dhawan R (1996). 
Hepatitis B virus infection in pregnant 
women and its transmission to infants. 
J. Trop. Ped. 42(6):352 - 354. 
45. Saleh-Gargari S, Hantoushzadeh S, 
Zendehdel N, Jamal A, Aghdam H 
(2009). The association of maternal 
HBsAg carrier status and perinatal 
outcome. J. Hep. 9(3): 180 - 184. 
46. To WW, Cheung W, Mok KM (2003). 
Hepatitis B surface antigen carrier 
status and its correlation to gestational 
hypertension. Aust. N. Z. J. Obstet. 
Gynaecol. 43:110-122. 
47. Tse KY, Ho LF, Lao T (2005). The 
impact of maternal HBsAg carrier status 
on pregnancy outcomes: a case- control 
study. J. Hepatol. 43:771-775. 
48. Lao TT, Chan BC, Leung WC, Ho LF, 
Tse KY (2007). Maternal Hepatitis B 
infection and gestational diabetes 
mellitus. J. Hepatol. 47: 46 - 50. 
49. Mi J, Law C, Zhang KI, Osmond C, 
Stein C, Barker D (2000). Effects of 
infant birth weight and maternal body 
mass index in pregnancy on 
components of the insulin resistance 
syndrome in China. Ann. Intern. Med. 
132: 253 - 260. 
50. Nithin J, Nithin H, Nitha J (2009). Risk 
Factors of Neonatal Sepsis in 
Trivandrum, Kerala. Retrieved from 
http://w.w.w.scribe.com>School 
Work>Essays & Theses. accessed 
28/04/2013@10:50am. 
51. Okasha M, Gunnell D, Holly J, Smith 
GD (2002). Childhood growth and adult 
cancer. Best Pract. Res. Clin. 
Endocrinal. Metab. 16:225 - 241.  
52. Shah GS, Budhathoki S, Das BK, 
Mandal RN (2006). Risk factors in early 
neonatal sepsis. Kathmandu Uni. Med. 
J. 4(14): 187 - 191. 
53. Shaheen AAM & Myers RP (2010). 
The outcomes of pregnancy in patients 
with cirrhosis: a population-based 
study. Liver Int. 30: 275 – 83. 
54. Sheron N, Lau J, Daniels H, Goka J, 
Eddleston A, Alexander GJM (1991). 
Increased production of tumor necrosis 
factor alpha in chronic hepatitis B virus 
infection. J. Hepatol. 12:241-245. 
55. Tan J, Surti B, Saab S (2008). 
Pregnancy and cirrhosis. Liver Transpl. 
14:1081–91. 
56. Vinodkumar CS, Neelagund YF, 
Kalsurmath S, Banapurmath S, 
Kalappannavar NK, Basavarajappa KG 
(2009). Perinatal Risk factors and 
microbial profile of neonatal 
septicemia: A multicentred study. J.  
Obst. and Gynecol. of India. 58: 32 - 
40. 
57. Webb P, Bain C (2011). Essential 
Epidemiology. Second edition. UK: 
Cambridge publishers. 
Sept. 2014. Vol. 4, No.5                                                                                                ISSN 2307-2083            
                           International Journal of Research In Medical and Health Sciences    
                                                    © 2013-2014 IJRMHS & K.A.J. All rights reserved                
                        http://www.ijsk.org/ijrmhs.html                                                                                                                                 
 
 
12 
 
58. West B, Tabansi PN (2012). Clinico-
Bacterial profile of early and late onset 
sepsis in a tertiary hospital in Nigeria. J. 
Medic. and Med. Sci. 3(2): 107-111. 
Available online at 
http://w.w.w.interesjournals.org/JMMS. 
59. West B, Tabansi PN (2012). Clinico-
Bacterial profile of early and late onset 
sepsis in a tertiary hospital in Nigeria. J. 
Medic. and Med. Sci. 3(2): 107-111. 
Available online at 
http://w.w.w.interesjournals.org/JMMS. 
60. Whincup PH, Kaye SJ, Owen CG, et al. 
(2008). Birth weight and risk of type 2 
diabetes. A systematic review. JAMA. 
300: 2886 - 2897. 
61. Wong S, Chan LY, Yu V, Ho L (1999). 
Hepatitis B Carrier and Perinatal 
Outcome in Singleton Pregnancy. Am. 
J. Perinatol. 16: 485 - 488. 
62. Wong DL, Perry S, Hockenberry MJ, 
Lowdermilk LD, Wilson D (2006). 
Maternal Child Nursing Care. 3rd 
edition. Mosby Elsevier. USA. 
63. World Health Organization (2000). 
Hepatitis B. Retrieved: August 23, 2013 
from http:// wwwwho.int/media 
centre/factsheets/fs 204/en/. 
View publication stats
